Drug Interaction of Fluvoxamine and Fluoxetine with Nevirapine in HIV-1-Infected Individuals

被引：0
|
作者：
Monique M. R. de Maat
Alwin D. R. Huitema
Jan W. Mulder
Pieter L. Meenhorst
Eric C. M. van Gorp
Albert T. A. Mairuhu
Jos H. Beijnen
机构：
[1] Slotervaart Hospital,Department of Pharmacy and Pharmacology
[2] Slotervaart Hospital,Department of Internal Medicine
[3] University of Utrecht,Faculty of Pharmaceutical Sciences
来源：
Clinical Drug Investigation | 2003年 / 23卷
关键词：
Fluoxetine; Lamivudine; Fluvoxamine; Nevirapine; Indinavir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：629 / 637
页数：8
相关论文
共 50 条
  • [31] Altered sialylation of alveolar macrophages in HIV-1-infected individuals
    Perrin, C
    Giordanengo, V
    Bannwarth, S
    Blaive, B
    Lefebvre, JC
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 110 (01): : 22 - 25
  • [32] Metabolic characterization of plasma samples in HIV-1-infected individuals
    Zhang, Ting
    Sun, Jianping
    Du, Haiwei
    Su, Haoxiang
    Zhang, Yonghong
    Jin, Qi
    FUTURE MICROBIOLOGY, 2018, 13 (09) : 985 - 996
  • [33] Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy
    Gradoni, L
    Scalone, A
    Gramiccia, M
    Troiani, M
    AIDS, 1996, 10 (07) : 785 - 791
  • [34] TOTAL INSOMNIA AS AN ACUTE EFFECT OF FLUVOXAMINE ADMINISTRATION IN 3 HIV-1-INFECTED PATIENTS
    GRASSI, B
    SCARONE, S
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1994, 9 (03) : 224 - 224
  • [35] Antiretroviral drug resistance among drug-naive HIV-1-infected individuals in Djibouti (Horn of Africa)
    Maslin, J
    Rogier, C
    Caron, M
    Grandadam, M
    Koeck, JL
    Nicand, E
    ANTIVIRAL THERAPY, 2005, 10 (07) : 855 - 859
  • [36] Efavirenz to nevirapine switch in HIV-1-infected patients with dyslipidemia: A randomized, controlled study
    Parienti, Jean-Jacques
    Massari, Veronique
    Rey, David
    Poubeau, Patrice
    Verdon, Renaud
    CLINICAL INFECTIOUS DISEASES, 2007, 45 (02) : 263 - 266
  • [37] Acute intoxication with nevirapine in an HIV-1-infected patient: clinical and pharmacokinetic follow up
    Elens, Laure
    Haufroid, Vincent
    Doyen, Chantal
    Vandercam, Bernard
    Yombi, Jean-Cyr
    AIDS, 2009, 23 (10) : 1291 - 1293
  • [38] Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy
    Martínez, E
    Blanco, JL
    Arnaiz, JA
    Pérez-Cuevas, JB
    Mocroft, A
    Cruceta, A
    Marcos, MA
    Milinkovic, A
    García-Viejo, MA
    Mallolas, J
    Carné, X
    Phillips, A
    Gatell, JM
    AIDS, 2001, 15 (10) : 1261 - 1268
  • [39] Archived HIV-1 DNA resistance mutations to rilpivirine and etravirine in successfully treated HIV-1-infected individuals pre-exposed to efavirenz or nevirapine
    Gallien, S.
    Charreau, I.
    Nere, M. L.
    Mahjoub, N.
    Simon, F.
    de Castro, N.
    Aboulker, J. P.
    Molina, J. M.
    Delaugerre, C.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (02) : 562 - 565
  • [40] Nevirapine Resistance in Previously Nevirapine-Unexposed HIV-1-Infected Kenyan Infants Initiating Early Antiretroviral Therapy
    Chohan, Bhavna H.
    Tapia, Kenneth
    Benki-Nugent, Sarah
    Khasimwa, Brian
    Ngayo, Musa
    Maleche-Obimbo, Elizabeth
    Wamalwa, Dalton
    Overbaugh, Julie
    John-Stewart, Grace
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (08) : 783 - 791
12345